Joel Greenblatt Rhythm Pharmaceuticals, Inc. Call Options Transaction History
Gotham Asset Management, LLC
- $7.56 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RYTM
# of Institutions
179Shares Held
68.7MCall Options Held
467KPut Options Held
224K-
Primecap Management CO Pasadena, CA7.31MShares$469 Million0.22% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$432 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$410 Million3.49% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$390 Million3.77% of portfolio
-
Goldman Sachs Group Inc New York, NY5.29MShares$339 Million0.04% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.57B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...